Empire State Realty Trust Welcomes L’Occitane, Inc. to 111 West 33rd Street

NEW YORK CITY, May 22, 2019 – Empire State Realty Trust, Inc. (NYSE: ESRT) announced today that L’Occitane, Inc., a leading global retailer of natural cosmetics and well-being products, signed a 20,962 sq. ft. lease at 111 West 33rd Street for the full 20th floor.

“L’Occitane, Inc., a great international brand, joins an exciting tenant roster at 111 West 33rd Street,” said Thomas P. Durels, Executive Vice President, Real Estate for ESRT. “Tenants are drawn to 111’s efficient floor plates, spectacular lobby, natural light and convenient access to Penn Station and the Herald Square transit hub.”

Mark Boisi, Gary Ceder and Laurence Carroll of Cushman & Wakefield, Inc. represented L’Occitane, Inc. Landlord representation was provided by Keith Cody from ESRT, and Scott J. Klau, Erik S. Harris, and Neil L. Rubin from Newmark Knight Frank.


About Empire State Realty TrustEmpire State Realty Trust, Inc. (NYSE: ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the “World’s Most Famous Building.” Headquartered in New York, New York, the Company’s office and retail portfolio covers 10.1 million rentable square feet, as of March 31, 2019, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut, and two in Westchester County, New York; and approximately 700,000 rentable square feet in the retail portfolio.

Forward-Looking StatementsThis press release may contain forward-looking statements within the meaning of the Federal securities laws. You can identify these statements by use of the words “assumes,” “believes,” “estimates,” “expects,” “intends,” “plans,” “projects” and similar expressions that do not relate to historical matters. You should exercise caution in relying on forward-looking statements, because they involve risks, uncertainties and other factors which are, in some cases, beyond ESRT’s control and could materially affect actual results. Such factors and risks include, without limitation, a failure of conditions or performance regarding any event or transaction described above, regulatory changes, and other risks and uncertainties described from time to time in ESRT’s filings with the SEC. Except as may be required by law, ESRT does not undertake a duty to update any forward-looking statement.